Expression and regulation of a disintegrin and metalloproteinase (ADAM) 8 in experimental asthma

American Journal of Respiratory Cell and Molecular Biology

Volumn 31, Issue 3, 2004, Pages 257-265

  King, Nina E ^a   Zimmermann, Nives ^a   Pope, Samuel M ^a   Fulkerson, Patricia C ^a   Nikolaidis, Nikolaos M ^a   Mishra, Anil ^a   Witte, David P ^a   Rothenberg, Marc E ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; COMPLEMENTARY DNA; DISINTEGRIN; INTERLEUKIN 13; INTERLEUKIN 4; MEMBRANE PROTEIN; METALLOPROTEINASE; OVALBUMIN; PROTEIN SUBUNIT; STAT6 PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; ASTHMA; BRONCHIOLE; CHRONOTHERAPY; DOSE RESPONSE; EXON; GENE IDENTIFICATION; GENE INDUCTION; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INDUCTION; SEQUENCE ANALYSIS;

ADAM PROTEINS; ALLERGENS; ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD; ASTHMA; BASE SEQUENCE; BRONCHI; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTERLEUKIN-13; INTERLEUKIN-4; LUNG; MEMBRANE PROTEINS; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, INTERLEUKIN-4; RESPIRATORY MUCOSA; RNA, MESSENGER; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; MURINAE;

EID: 4444368197     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2004-0026OC     Document Type: Article

References (57)

1. ISAAC. 1998. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 351:1225-1232.
2. Broide, D. H. 2001. Molecular and cellular mechanisms of allergic disease. J. Allergy Clin. Immunol. 108:S65-S71.
3. Hogan, S. P., A. Koskinen, K. I. Matthaei, I. G. Young, and P. S. Foster. 1998. Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice. Am. J. Respir. Crit. Care Med. 157:210-218.
4. Robinson, D. S., Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans, A. M. Bentley, C. Corrigan, S. R. Durham, and A. B. Kay. 1992. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
5. Ray, A., and L. Cohn. 1999. Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation. J. Clin. Invest. 104:985-993.
6. Wills-Karp, M. 1999. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu. Rev. Immunol. 17:255-281.
7. Bochner, B. S., B. J. Undem, and L. M. Lichtenstein. 1994. Immunological aspects of allergic asthma. Annu. Rev. Immunol. 12:295-335.
8. Brusselle, G. G., J. C. Kips, J. H. Tavernier, J. G. van der Heyden, C. A. Cuvelier, R. A. Pauwels, and H. Bluethmann. 1994. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin. Exper. Allergy 24:73-80.
9. Rankin, J. A., D. E. Picarella, G. P. Geba, U.-A. Temann, B. Prasad, B. DiCosmo, A. Tarallo, B. Stripp, J. Whitsett, and R. A. Flavell. 1996. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc. Natl. Acad. Sci. USA 93:7821-7825.
10. Tepper, R. I., D. A. Levinson, B. Z. Stanger, J. Campos-Torres, A. K. Abbas, and P. Leder. 1990. IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 62:457-467.
11. Emson, C. L., S. E. Bell, A. Jones, W. Wisden, and A. N. McKenzie. 1998. Interleukin (IL)-4-independent induction of immunoglobulin (Ig) E, and perturbation of T cell development in transgenic mice expressing IL-13. J. Exp. Med. 188:399-404.
12. Zurawski, G., and J. E. de Vries. 1994. Interleukin-13, an interleukin-4 like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 15:19-26.
13. Bochner, B. S., D. A. Klunk, S. A. Sterbinsky, R. L. Coffman, and R. P. Schleimer. 1995. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J. Immunol. 154:799-803.
14. Horie, S., Y. Okubo, M. Hossain, E. Sato, H. Nomura, S. Koyama, J. Suzuki, H. Isobe, and M. Sekiguchi. 1997. Interleukin-13 but not interleukin-4 prolongs eosinophil survival and induces eosinophil chemotaxis. Intern. Med. 36:179-185.
15. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282:2258-2261.
16. Lai, S. Y., J. Molden, K. D. Liu, J. M. Puck, M. D. White, and M. A. Goldsmith. 1996. Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit. EMBO J. 15: 4506-4514.
17. Izuhara, K., T. Heike, T. Otsuka, K. Yamaoka, M. Mayumi, T. Imamura, Y. Niho, and N. Harada. 1996. Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients. J. Biol. Chem. 271:619-622.
18. Takeda, K., M. Kamanaka, T. Tanaka, T. Kishimoto, and S. Akira. 1996. Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. J. Immunol. 157:3220-3222.
19. Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura, K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira. 1996. Essential role of Stat6 in IL-4 signalling. Nature 380:627-630.
20. Murata, T., P. D. Noguchi, and R. K. Puri. 1996. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling. J. Immunol. 156:2972-2978.
21. Barnes, P. J. 2000. New directions in allergic diseases: mechanism-based antiinflammatory therapies. J. Allergy Clin. Immunol. 106:5-16.
22. Boushey, H. A., Jr. 2001. Experiences with monoclonal antibody therapy for allergic asthma. J. Allergy Clin. Immunol. 108:S77-S83.
23. Zimmermann, N., N. E. King, J. Laporte, M. Yang, A. Mishra, S. M. Pope, E. E. Muntel, D. P. Witte, A. E. Pegg, P. S. Foster, Q. Hamid, and M. E. Rothenberg. 2003. Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J. Clin. Invest. 111: 1863-1874.
24. Kurup, V. P., S. Mauze, H. Choi, B. W. Seymour, and R. L. Coffman. 1992. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. J. Immunol. 148:3783-3788.
25. Primakoff, P., and D. G. Myles. 2000. The ADAM gene family: surface proteins with adhesion and protease activity. Trends Genet. 16:83-87.
26. Yamamoto, S., Y. Higuchi, K. Yoshiyama, E. Shimizu, M. Kataoka, N. Hijiya, and K. Matsuura. 1999. ADAM family proteins in the immune system. Immunol. Today 20:278-284.
27. Black, R. A., C. T. Rauch, C. J. Kozlosky, J. J. Peschon, J. L. Slack, M. F. Wolfson, B. J. Castner, K. L. Stocking, P. Reddy, S. Srinivasan, N. Nelson, N. Boiani, K. A. Schooley, M. Gerhart, R. Davis, J. N. Fitzner, R. S. Johnson, R. J. Paxton, C. J. March, and D. P. Cerretti. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385:729-733.
28. Gough, P. J., K. J. Garton, P. T. Wille, M. Rychlewski, P. J. Dempsey, and E. W. Raines. 2004. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J. Immunol. 172:3678-3685.
29. Van Eerdewegh, P., R. D. Little, J. Dupuis, R. G. Del Mastro, K. Falls, J. Simon, D. Torrey, S. Pandit, J. McKenney, K. Braunschweiger, A. Walsh, Z. Liu, B. Hayward, C. Folz, S. P. Manning, A. Bawa, L. Saracino, M. Thackston, Y. Benchekroun, N. Capparell, M. Wang, R. Adair, Y. Feng, J. Dubois, M. G. FitzGerald, H. Huang, R. Gibson, K. M. Allen, A. Pedan, M. R. Danzig, S. P. Umland, R. W. Egan, F. M. Cuss, S. Rorke, J. B. Clough, J. W. Holloway, S. T. Holgate, and T. P. Keith. 2002. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418:426-430.
30. Howard, T. D., D. S. Postma, H. Jongepier, W. C. Moore, G. H. Koppelman, S. L. Zheng, J. Xu, E. R. Bleecker, and D. A. Meyers. 2003. Association of a disintegrin and metalloproteinase 33 (ADAM33) gene with asthma in ethnically diverse populations. J. Allergy Clin. Immunol. 112:717-722.
31. Fourie, A. M., F. Coles, V. Moreno, and L. Karlsson. 2003. Catalytic activity of ADAM8, ADAM15 and MDC-L (ADAM28) on synthetic peptide substrates, and in ectodomain cleavage of CD23. J. Biol. Chem. 278:30469-30477.
32. McKenzie, G. J., P. G. Fallon, C. L. Emson, R. K. Grencis, and A. N. McKenzie. 1999. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses. J. Exp. Med. 189: 1565-1572.
33. Shimoda, K., J. van Deursen, M. Y. Sangster, S. R. Sarawar, R. T. Carson, R. A. Tripp, C. Chu, F. W. Quelle, T. Nosaka, D. A. Vignali, P. C. Doherty, G. Grosveld, W. E. Paul, and J. N. Ihle. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380:630-633.
34. Zimmermann, N., S. P. Hogan, A. Mishra, E. B. Brandt, T. R. Bodette, S. M. Pope, F. D. Finkelman, and M. E. Rothenberg. 2000. Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression. J. Immunol. 165:5839-5846.
35. Wan, H., K. H. Kaestner, S.-L. Ang, M. Ikegami, F. D. Finkelman, M. T. Stahlman, P. C. Fulkerson, M. E. Rothenberg, and J. A. Whitsett. 2004. Foxa2 regulates alveolarization and goblet cell hyperplasia. Development 131:953-964.
36. Tichelaar, J. W., W. Lu, and J. A. Whitsett. 2000. Conditional expression of fibroblast growth factor-7 in the developing and mature lung. J. Biol. Chem. 275:11858-11864.
37. Mishra, A., T. E. Weaver, D. C. Beck, and M. E. Rothenberg. 2001. Interleukin-5-mediated allergic airway inflammation inhibits the human surfactant protein C promoter in transgenic mice. J. Biol. Chem. 276:8453-8459.
38. Finkelman, F. D., K. B. Madden, S. C. Morris, J. M. Holmes, N. Boiani, I. M. Katona, and C. R. Maliszewski. 1993. Anti-cytokine antibodies as carrier proteins: prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes. J. Immunol. 151:1235-1244.
39. Matthews, A. N., D. S. Friend, N. Zimmermann, M. N. Sarafi, A. D. Luster, E. Pearlman, S. E. Wert, and M. E. Rothenberg. 1998. Eotaxin is required for the baseline level of tissue eosinophils. Proc. Natl. Acad. Sci. USA 95: 6273-6278.
40. Foster, P. S., A. W. Mould, M. Yang, J. Mackenzie, J. Mattes, S. P. Hogan, S. Mahalingam, A. N. McKenzie, M. E. Rothenberg, I. G. Young, K. I. Matthaei, and D. C. Webb. 2001. Elemental signals regulating eosinophil accumulation in the lung. Immunol. Rev. 179:173-181.
41. Hamelmann, E., J. Schwarze, K. Takeda, A. Oshiba, G. L. Larsen, C. G. Irvin, and E. W, Gelfand. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 156:766-775.
42. Zhu, Z., R. J. Homer, Z. Wang, Q. Chen, G. P. Geba, J. Wang, Y. Zhang, and J. A. Elias. 1999. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J. Clin. Invest. 103:779-788.
43. Yoshida, S., M. Setoguchi, Y. Higuchi, S. Akizuki, and S. Yamamoto. 1990. Molecular cloning of cDNA encoding MS2 antigen, a novel cell surface antigen strongly expressed in murine monocytic lineage. Int. Immunol. 2:585-591.
44. Yoshiyama, K., Y. Higuchi, M. Kataoka, K. Matsuura, and S. Yamamoto. 1997. CD156 (human ADAM8): expression, primary amino acid sequence, and gene location. Genomics 41:56-62.
45. Armant, M., H. Ishihara, M. Rubio, G. Delespesse, and M. Sarfati. 1994. Regulation of cytokine production by soluble CD23: costimulation of interferon γ secretion and triggering of tumor necrosis factor α release. J. Exp. Med. 180:1005-1011.
46. Armant, M., M. Rubio, G. Delespesse, and M. Sarfati. 1995. Soluble CD23 directly activates monocytes to contribute to the antigen-independent stimulation of resting T cells. J. Immunol 155:4868-4875.
47. Bonnefoy, J. Y., C. Plater-Zyberk, S. Lecoanet-Henchoz, J. Gauchat, J. Aubry, and P. Graber. 1996. A new role for CD23 in inflammation. Immunol. Today 17:418-420.
48. Delespesse, G., U. Suter, D. Mossalayi, B. Bettler, M. Sarfati, H. Hofstetter, E. Kilcherr, P. Debre, and A. Dalloul. 1991. Expression, structure, and function of the CD23 antigen. Adv. Immunol. 49:149-191.
49. Cernadas, M., G. T. De Sanctis, S. J. Krinzman, D. A. Mark, C. E. Donovan, J. A. Listman, L. Kobzik, H. Kikutani, D. C. Christiani, D. L. Perkins, and P. W. Finn. 1999. CD23 and allergic pulmonary inflammation: potential role as an inhibitor. Am. J. Respir. Cell Mol. Biol. 20:1-8.
50. Dasic, G., P. Juillard, P. Graber, S. Herren, T. Angell, R. Knowles, J. Y. Bonnefoy, M. H. Kosco-Vilbois, and Y. Chvatchko. 1999. Critical role of CD23 in allergen-induced bronchoconstriction in a murine model of allergic asthma. Eur. J. Immunol. 29:2957-2967.
51. Haczku, A., H. Takeda, E. Hamelmann, J. Loader, A. Joetham, I. Redai, C. G. Irvin, J. J. Lee, H. Kikutani, D. Conrad, and E. W. Gelfand. 2000. CD23 exhibits negative regulatory effects on allergic sensitization and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 161:952-960.
52. Kataoka, M., K. Yoshiyama, K. Matsuura, N. Hijiya, Y. Higuchi, and S. Yamamoto. 1997. Structure of the murine CD156 gene, characterization of its promoter, and chromosomal location. J. Biol. Chem. 27:18209-18215.
53. Schlomann, U., S. Rathke-Hartlieb, S. Yamamoto, H. Jockusch, and J. W. Bartsch. 2000. Tumor necrosis factor α induces a metalloproteinase- disintegrin, ADAM8 (CD 156): implications for neuron-glia interactions during neurodegeneration. J. Neurosci. 20:7964-7971.
54. Jegga, A. G., S. P. Sherwood, J. W. Carman, A. T. Pinski, J. L. Phillips, J. P. Pestian, and B. J. Aronow. 2002. Detection and visualization of compositionally similar cis-regulatory element clusters in orthologous and coordinately controlled genes. Genome Res. 12:1408-1417.
55. Garlisi, C. G., J. Zou, K. E. Devito, F. Tian, F. X. Zhu, J. Liu, H. Shah, Y. Wan, M. Motasim Billah, R. W. Egan, and S. P. Umland. 2003. Human ADAM33: protein maturation and localization. Biochem. Biophys. Res. Commun. 301:35-43.
56. Lind, D. L., S. Choudhry, N. Ung, E. Ziv, P. C. Avila, K. Salari, C. Ha, E. G. Lovins, N. E. Coyle, S. Nazario, J. Casal, A. Torres, J. R. Rodriguez-Santana, H. Matallana, C. M. Lilly, J. Salas, M. Selman, H. A. Boushey, S. T. Weiss, R. Chapela, J. G. Ford, W. Rodriguez-Cintron, E. K. Silverman, D. Sheppard, P. Y. Kwok, and E. Gonzalez Burchard. 2003. ADAM33 is not associated with asthma in Puerto Rican or Mexican populations. Am. J. Respir. Crit. Care Med. 168:1312-1316.
57. Higuchi, Y., A. Yasui, K. Matsuura, and S. Yamamoto. 2002. CD156 transgenic mice: different responses between inflammatory types. Pathobiology 70: 47-54.